btourbier

Innovation in Diabetes: European Action Summit

This year again, leading actors in Diabetes will join us for 2 days of intensive partnering and networking!

Following the success of 2 previous editions (in Lund, Sweden in September 2013 and in Lille, France in December 2014 within BioFIT 2014), the 3^rd edition of IDEA Summit, the unique European event dedicated to translational research on diabates will be held on November 30^th & December  1^st, 2015 in Strasbourg, France during BioFIT 2015.

With a one-day conference program dedicated to sheld the light on recent innovation and clinical achievement in the field of diabetes on November 30th, following by a one-to-one partnering session provided by BioFIT enabling Pharma, Biotech, TTO’s & Academic scientists to explore licensing and collaborative opportunities on December 1^st, 2015*; IDEA Summit aims to stimulate academia-industry interaction and identify initiatives that can accelerate the pace of innovation in the diabetes area.

For more information, please contact Margaux SATOLA: msatola@eurasante.com

* possibility to continue the partnering activity on December 2^nd with BioFIT!

 

You are involved in Life Sciences & want to meet the leading stakeholders of the sector?

Come to BioFIT, the international partnering event in Europe for open innovation, technology transfer and collaborative research which gathers the leaders in the field of Life Sciences.

Do not hesitate anymore! Register before June 30th, 2015 and benefit from the Early Bird rate and save up to €240!

We are honored to count Swiss Biotech Association as one of our supporter for BioFIT 2015.

SBA is the industry association of the Swiss companies active in modern biotechnology in either R&D, manufacturing or services. Their members are from all majors sectors of the industry, such as pharmaceuticals (therapy and disgnostics), bio and chemical, reagents and equipment for biotechnological processes.

You want to meet Swiss Biotech Association or their members, join us at BioFIT !

BioFIT team will be in Lyon, France, to attend BioVision on April 15th & 16th.

BioVision is an annual forum dedicated to prospective in Life Sciences.

Beyond the foresight, BioVision’s ambition is to facilitate collaboration between different actors, innovation and ultimately access to knowledge and solutions for the general public.

Take advantage of that perfect opening to get an extensive overview of BioFIT activities, or just have a chat with our team!

Contact: Margaux Satola, BioFIT Project Manager

 

You didn’t get the opportunity to meet us at BIO-Europe Spring? We will be in Paris at the exhibition of laboratory materials and services suppliers “Forum LABO & BIOTECH, on April 1^st.

Take advantage of that perfect opening to meet us and get an overview of BioFIT activities, or just have a chat with our team!

 

Contact:

Anaïs Schoreel, Business Project Officer: aschoreel@eurasante.com

Mathieu Evrard, Commercial Manager: mevrard@eurasante.com

BioFIT team will be in Paris at the information day on the theme of innovation for rare diseases, organized by the “Fondation des maladies rares” and “AP-HP” on March 31^st.

Take advantage of that perfect occasion to meet us and get an overview of BioFIT activities, or just have a chat with our team!

 

Contact:

Anaïs Schoreel, Business Project Officer: aschoreel@eurasante.com

During the last edition of BioFIT in 2014, the French syndicate for veterinary drug (SIMV) initiated the 1^st European Business Convention dedicated to animal health.
More than 40 companies, 37 public research teams and 180 delegates involved in animal health met in order to accelerate the transfer between human and veterinary medicine.

In total, 400 one-to-one meetings have been scheduled with all the attendees.

Join them for the next edition of the R&D Dating for Animal Health and Innovation to be held on December 1^st & 2^nd in Strasbourg, during BioFIT 2015!

BioFIT team and NHL Cluster will be in Paris, FR, to attend BIO-Europe Spring on March 9^th to 11^th.

BIO-Europe Spring continues this year the tradition of providing life science companies with high caliber partnering opportunities.That is everything needed to enable delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, but most of all, a perfect occasion to come and meet us !

Take advantage of that perfect opening to get an extensive overview of BioFIT activities,or just have a chat with our team!

 

Contact :

BioFIT

Etienne Vervaecke, General Manager Eurasanté

Margaux Satola BioFIT Project Manager

NHL Cluster

Alexandre Labé, Director of Development

Gauthier Trublin, Biotechnologies Project Manager

The Posters and Presentations session is organized in partnership with the LEEM (Les Entreprises du Médicament).

Agenda – DECEMBER 2nd

TIME	COMPANY	SPEAKER	POSITION	TITLE
2.00pm	ABUNDNZ	Robert-Jan LAMERS	Managing Director	Ultrasensitive assay for bioanalytical studies with innovative medicines
2.15pm	CAPSULAE	Victor ROULLIER	Project Manager	Microencapsulation as a solution for therapeutic applications
2.30pm	CYANAGEN	Rossana PERCIACCANTE	R&D Manager	Novel fluorescent IR-marker for monitoring the kidney function
2.45pm	VITAMFERO	Pascal BRETON	Chief Executive Officer	VitamFero : a novel generation of veterinary live attenuated prophylactic treatments.
3.00pm	DELPHI GENETICS	Cédic SZPIRER	CEO / CSO	The Staby® technology: No antibiotics and higher yields in recombinant proteins, pDNA productions and antibody development
3.15pm	IMSTAR	Françoise SOUSSALINE	President & CEO	Innovative Image Cytometry Solutions for biomarkers identification and validation in research and cyto-pathology
4.00pm	INMOTE MEDTECH	Bart Groothuijze	CEO	Inmote MedTech: Easy, secure and consistent documentation in woundcare
4.15pm	JAGIELLONIAN UNIVERSITY	Radoslaw RUDZ	Head of Innovation Team CITTRU	Novel antiviral agents against coronaviruses
4.30pm	OCR	Matthieu DUBRUQUE	COO	OCR – The OneHealth Company
4.45pm	QUINTEN	Quentin PERRON	Head of Chemistry	Quinten: Expert in strategic data leveraging.
5.00pm	2BIND	Thomas SCHUBERT	CEO	Fast and quantitative analysis of molecular interactions using the MicroScale Thermophoresis (MST)
5.15pm	3M	Catherine BINEAU	Laboratory Engineer Life Science Specialist	3M EMPHAZE AEX HYBRID PURIFIER: Purification to the next level
5.30pm	4P PHARMA	Itschak LAMENSDORF	Chief Scientific Officer	Translating science to product: General methodolodgy for addressing technological and financial Challenges